These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 201505)

  • 1. Macrophage-induced reversal of immunosuppression by leukemia viruses.
    Specter SC; Bendinelli M; Ceglowski WS; Friedman H
    Fed Proc; 1978 Jan; 37(1):97-101. PubMed ID: 201505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression of humoral immunity to sheep erythrocytes in vitro by Friend virus leukemic spleen cells: induction of resistance by statolon.
    Weislow OS; Wheelock EF
    J Immunol; 1975 Jan; 114(1 Pt 1):211-5. PubMed ID: 1089711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppression by leukemia viruses. Effect of Friend leukemia virus on humoral immune competence of leukemia-resistant C57BL/6 mice.
    Ceglowski WS; Campbell BP; Friedman H
    J Immunol; 1975 Jan; 114(1 Pt 1):231-6. PubMed ID: 1089712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of adoptive transfer and Winn assay procedures in the further analysis of antiviral acquired immunity in mice protected against Friend leukemia virus-induced disease by passive serum therapy.
    Genovesi EV; Pettey CL; Collins JJ
    Cancer Res; 1984 Apr; 44(4):1489-98. PubMed ID: 6608407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired macrophage function in Friend virus leukemia: restoration by statolon.
    Levy MH; Wheelock EF
    J Immunol; 1975 Mar; 114(3):962-5. PubMed ID: 1167568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of leukemia virus-induced immunosuppression in vitro by peritoneal macrophages.
    Bendinelli M; Kaplan GS; Friedman H
    J Natl Cancer Inst; 1975 Dec; 55(6):1425-32. PubMed ID: 1107576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
    Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
    J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous regression of Friend virus-induced erythroleukemia. III. The role of macrophages in regression.
    Marcelletti J; Furmanski P
    J Immunol; 1978 Jan; 120(1):1-8. PubMed ID: 203629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-induced immunosuppression.
    Friedman H; Specter S; Watanabe M; Pan SH
    Am J Pathol; 1978 Nov; 93(2):499-514. PubMed ID: 102206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
    Ting CC; Rodrigues D
    J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.
    Tonietti G; Rossi GB; Del Gobbo V; Accinni L; Ranucci A; Titti F; Premrov MG; Garaci E
    Cancer Res; 1983 Sep; 43(9):4355-63. PubMed ID: 6347370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression by spleen cells from Moloney leukemia. III. Evidence for a suppressor cell that is not the leukemic, virus-producing cell.
    Cerny J; Grinwich KD; Stiller RA
    J Immunol; 1977 Sep; 119(3):1097-101. PubMed ID: 330747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular and serum involvement in protection against Friend leukemia virus.
    Schuller GB; Morahan PS
    Cancer Res; 1977 Nov; 37(11):4064-9. PubMed ID: 908040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression induced by attenuated Salmonella. Reversal by IL-4.
    al-Ramadi BK; Chen YW; Meissler JJ; Eisenstein TK
    J Immunol; 1991 Sep; 147(6):1954-61. PubMed ID: 1909735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of peritoneal exudate macrophages to reverse immunologic impairment by Friend leukemia virus.
    Ceglowski WS; Friedman H
    Proc Soc Exp Biol Med; 1975 Mar; 148(3):808-12. PubMed ID: 1093193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia virus-induced immunosuppression. IX. Depression of delayed hypersensitivity and MIF production after infection of mice with Friend leukemia virus.
    Mortensen RF; Ceglowski WS; Friedman H
    J Immunol; 1973 Dec; 111(6):1810-9. PubMed ID: 4584404
    [No Abstract]   [Full Text] [Related]  

  • 20. Dynamics of lymphocytic subpopulations in Friend leukemia virus-induced leukemia.
    Kitagawa M; Matsubara O; Kasuga T
    Cancer Res; 1986 Jun; 46(6):3034-9. PubMed ID: 2870802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.